(Q47325378)

14 January 2018

title

Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose (English)

1 reference

14 January 2018

1 reference

3

George Sandusky

1 reference

14 January 2018

author name string

John L Vahle

1

1 reference

14 January 2018

Gerald G Long

2

1 reference

14 January 2018

Michael Westmore

4

1 reference

14 January 2018

Yanfei Linda Ma

5

1 reference

14 January 2018

Masahiko Sato

6

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

14 January 2018

published in

Toxicologic Pathology

1 reference

14 January 2018

volume

32

1 reference

14 January 2018

issue

4

1 reference

14 January 2018

page(s)

426-438

1 reference

14 January 2018

Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Overall false positive rates in tests for linear trend in tumor incidence in animal carcinogenicity studies of new drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

The anabolic effects of parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230490462138

10.1080/01926230490462138

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018